Corrigendum: Case report: A sustained survival benefit of third-line immunotherapy for refractory thymic carcinoma - Meng, Mi; Yu, Bo; Luo, Jie; Bai, Yuju; Li, Lin; Chen, Shicheng; He, Sisi; Ma, Hu (Frontiers in Oncology, 2024)